About 14 results found for searched term "K22" (0.097 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2007 | Romidepsin (FK228) | HDAC |
| FK228; ISTODAX; Depsipeptide; FR 901228; NSC 630176 | ||
| Romidepsin (FK228, Depsipeptide, FR 901228, NSC 630176) is a structurally unique, potent HDAC1 and HDAC2 inhibitor with IC50 of 36 nM and 47 nM, respectively.*The compound is unstable in solutions, freshly prepared is recommended | ||
| M3792 | Vatalanib | VEGFR/PDGFR |
| CGP-7978, PTK 787, ZK222584 | ||
| Vatalanib is an inhibitor of the VEGFR tyrosine kinases VEGFR-1 (Flt-1, IC₅₀ = 77 nM) and VEGFR-2 (FLK-1/KDR, IC₅₀ = 37 nM), with slightly higher potency against the latter. | ||
| M5231 | GSK2269557 | PI3K |
| Nemiralisib; GSK-2269557 | ||
| Nemiralisib, also known as GSK-2269557, is a potent and selective PI3Kδ inhibitor(pKi = 9.9). | ||
| M6139 | GSK2256098 | FAK |
| GTPL7939 | ||
| GSK2256098 is a potent, selective, reversible, and ATP competitive FAK kinase inhibitor with apparent Ki of 0.4 nM. | ||
| M9148 | SRT2104 | Sirtuin |
| GSK2245840 | ||
| SRT2104 is a first-in-class, selective, blood-brain barrier-crossing SIRT1 activator for use in studies related to diabetes and Huntington's disease. | ||
| M9178 | GSK2292767 | PI3K |
| GSK2292767 is a potent and selective PI3Kδ inhibitor. | ||
| M10824 | GSK2245035 | TLR |
| GSK2245035 is a highly potent, selective intranasal Toll-Like receptor 7 (TLR7) agonist with preferential stimulation of interferon type 1 (IFN). GSK2245035 for IFNα and TNFα pEC50 9.3 and 6.5, respectively. GSK2245035 effectively inhibits allergen-induced Th2 cytokine production in human peripheral blood cell cultures. GSK2245035 has the potential for asthma. | ||
| M11467 | GSK-2250665A | Itk |
| GSK2250665; GSK-2250665 | ||
| GSK-2250665A is a Itk inhibitor with pKi value of 9.2. | ||
| M14423 | GSK2256294A | Epoxide Hydrolase |
| GSK 2256294 | ||
| GSK2256294A is a potent, reversible, tight binding inhibitor of isolated recombinant human sEH (soluble epoxide hydrolase) (IC50 = 27 pM; t1/2 = 121 min) and displays potent inhibition against the rat (IC50 = 61 pM) and murine (IC50 = 189 pM) orthologs of sEH. | ||
| M28023 | GSK2239633A | CCR |
| GSK2239633A is a CC-chemokine receptor 4 (CCR4) antagonist, which inhibits the binding of [125I]-TARC to human CCR4 with a pIC50 of 7.96 ± 0.11. | ||
| M28445 | GSK2200150A | Antibiotic |
| GSK2200150A, identified by high-throughput screening (HTS) campaign, is an anti-tuberculosis (TB) agent. | ||
| M28948 | GSK2226649A | Others |
| GSK2226649A (compound 2) is a novel activator of satellite cell proliferation and enhanced repair of damaged muscle. | ||
| M29632 | M4K2234 | ALK |
| M4K2234 (compound 26b) is an ALK2 inhibitor. M4K2234 inhibits ALK2 and ALK5 with IC50s of 5 and 2144 nM, respectively. M4K2234 can be used as a chemical probe for ALK1 and ALK2 protein kinases. M4K2234 can be used for the research of cancer. | ||
| M57754 | K22 | Anti-infection |
| ZIKV inhibitor K22 | ||
| K22 is an inhibitor of coronavirus RNA synthesis that specifically targets membrane-associated coronavirus RNA synthesis. K22 effectively blocks replication of multiple coronaviruses by inhibiting the critical step of viral replication complex anchoring to host cell membranes to form double-membrane vesicles (DMVs). K22 exhibits broad-spectrum antiviral activity against diverse coronaviruses. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
